| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/05/2023 | 6.91% | Piper Sandler | → $15 | Downgrades | Overweight → Neutral |
| 08/17/2023 | 6.91% | Evercore ISI Group | $14 → $15 | Maintains | In-Line |
| 08/08/2023 | -28.72% | B of A Securities | $12 → $10 | Downgrades | Neutral → Underperform |
| 08/04/2023 | 14.04% | Raymond James | $17 → $16 | Maintains | Outperform |
| 06/13/2023 | 6.91% | Wells Fargo | $16 → $15 | Maintains | Overweight |
| 05/10/2023 | -14.47% | Citigroup | $16 → $12 | Maintains | Neutral |
| 04/10/2023 | 6.91% | JP Morgan | $20 → $15 | Maintains | Neutral |
| 04/05/2023 | 6.91% | Piper Sandler | $13 → $15 | Upgrades | Neutral → Overweight |
| 03/30/2023 | -14.47% | BMO Capital | $13 → $12 | Maintains | Underperform |
| 03/23/2023 | 21.17% | Raymond James | $23 → $17 | Maintains | Outperform |
| 03/21/2023 | -7.34% | Piper Sandler | $18 → $13 | Maintains | Neutral |
| 03/16/2023 | 14.04% | Wells Fargo | $18 → $16 | Maintains | Overweight |
| 03/03/2023 | -7.34% | BMO Capital | $21 → $13 | Downgrades | Market Perform → Underperform |
| 02/08/2023 | 28.3% | Piper Sandler | → $18 | Maintains | Neutral |
| 01/09/2023 | 14.04% | Credit Suisse | → $16 | Downgrades | Outperform → Neutral |
| 01/03/2023 | -7.34% | Jefferies | $17 → $13 | Downgrades | Hold → Underperform |
| 12/12/2022 | 14.04% | Citigroup | $17 → $16 | Maintains | Neutral |
| 10/18/2022 | 42.55% | Wells Fargo | $24 → $20 | Maintains | Overweight |
| 10/18/2022 | 63.93% | Raymond James | $28 → $23 | Maintains | Outperform |
| 10/07/2022 | 35.42% | Piper Sandler | $30 → $19 | Downgrades | Overweight → Neutral |
| 09/27/2022 | 71.06% | Evercore ISI Group | $27 → $24 | Downgrades | Outperform → In-Line |
| 08/30/2022 | 71.06% | Wells Fargo | $28 → $24 | Maintains | Overweight |
| 08/04/2022 | 99.57% | Raymond James | $38 → $28 | Maintains | Outperform |
| 07/01/2022 | 99.57% | Wells Fargo | $38 → $28 | Maintains | Overweight |
| 06/30/2022 | 71.06% | Jefferies | $31 → $24 | Maintains | Hold |
| 06/23/2022 | 92.44% | Credit Suisse | → $27 | Initiates Coverage On | → Outperform |
| 06/07/2022 | 128.08% | JP Morgan | $38 → $32 | Maintains | Neutral |
| 05/09/2022 | 170.85% | Raymond James | $41 → $38 | Maintains | Outperform |
| 03/03/2022 | 163.72% | Evercore ISI Group | → $37 | Upgrades | In-Line → Outperform |
| 01/10/2022 | 192.23% | Raymond James | → $41 | Upgrades | Market Perform → Outperform |
| 12/14/2021 | 170.85% | Wells Fargo | → $38 | Upgrades | Equal-Weight → Overweight |
| 06/03/2021 | 185.1% | Mizuho | $32 → $40 | Upgrades | Neutral → Buy |
| 01/12/2021 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 01/07/2021 | 106.7% | Baird | → $29 | Downgrades | Outperform → Neutral |
| 11/25/2020 | 142.34% | Evercore ISI Group | → $34 | Downgrades | Outperform → In-Line |
| 11/16/2020 | 120.96% | B of A Securities | $29 → $31 | Maintains | Neutral |
| 11/04/2020 | 113.83% | Piper Sandler | $33 → $30 | Maintains | Overweight |
| 10/27/2020 | 120.96% | Scotiabank | $30 → $31 | Maintains | Sector Perform |
| 09/23/2020 | 135.21% | Wells Fargo | $40 → $33 | Maintains | Equal-Weight |
| 08/24/2020 | 113.83% | Citigroup | $31 → $30 | Maintains | Neutral |
| 08/12/2020 | 128.08% | Jefferies | $34 → $32 | Downgrades | Buy → Hold |
| 07/15/2020 | 170.85% | Raymond James | $40 → $38 | Maintains | Outperform |
| 06/10/2020 | 185.1% | Wells Fargo | $45 → $40 | Maintains | Equal-Weight |
| 05/28/2020 | 120.96% | Citigroup | $30 → $31 | Maintains | Neutral |
| 05/06/2020 | 156.59% | JP Morgan | $44 → $36 | Maintains | Neutral |
| 04/28/2020 | 120.96% | Mizuho | $45 → $31 | Maintains | Neutral |
| 04/16/2020 | 156.59% | Jefferies | $36 → $36 | Initiates Coverage On | → Buy |
| 04/07/2020 | 113.83% | Citigroup | $42 → $30 | Maintains | Neutral |
| 04/03/2020 | 163.72% | Stifel | $47 → $37 | Maintains | Buy |
| 03/25/2020 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
| 02/13/2020 | 256.38% | Baird | $51 → $50 | Maintains | Outperform |
| 02/04/2020 | 220.74% | Mizuho | → $45 | Initiates Coverage On | → Neutral |
| 01/15/2020 | 213.61% | Mizuho | → $44 | Downgrades | Buy → Neutral |
| 01/14/2020 | 213.61% | Barclays | $47 → $44 | Maintains | Equal-Weight |
| 11/08/2019 | 235% | Raymond James | $45 → $47 | Maintains | Outperform |
| 02/04/2019 | 177.98% | Barclays | $37 → $39 | Upgrades | Underweight → Equal-Weight |
| 12/20/2018 | — | Janney Montgomery Scott | Upgrades | Neutral → Buy | |
| 11/15/2018 | 199.36% | Piper Sandler | → $42 | Upgrades | Hold → Buy |
| 11/13/2018 | 192.23% | B of A Securities | $42.5 → $41 | Downgrades | Buy → Neutral |
| 11/05/2018 | 199.36% | Raymond James | $44 → $42 | Maintains | Outperform |
| 09/10/2018 | 202.92% | B of A Securities | $44 → $42.5 | Maintains | Buy |
What is the target price for Douglas Emmett (DEI)?
The latest price target for Douglas Emmett (NYSE: DEI) was reported by Piper Sandler on September 5, 2023. The analyst firm set a price target for $15.00 expecting DEI to rise to within 12 months (a possible 6.91% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Douglas Emmett (DEI)?
The latest analyst rating for Douglas Emmett (NYSE: DEI) was provided by Piper Sandler, and Douglas Emmett downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Douglas Emmett (DEI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Douglas Emmett, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Douglas Emmett was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
Is the Analyst Rating Douglas Emmett (DEI) correct?
While ratings are subjective and will change, the latest Douglas Emmett (DEI) rating was a downgraded with a price target of $0.00 to $15.00. The current price Douglas Emmett (DEI) is trading at is $14.03, which is within the analyst's predicted range.